Ftse Mib
34.089,60
0,77%
DAX
20.171,07
0,68%
S&P 500
6.049,88
0,05%
NASDAQ
19.480,91
0,40%
Bitcoin
96.561,13
0,62%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IO Biotech Inc (IOBT) IO Biotech Inc (IOBT) Notizie

IO Biotech Inc

IOBT
0,8602
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:02:24
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/11/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:11EDGAR2Form 8-K - Current report
12/11/202413:05GLOBEIO Biotech Reports Third Quarter 2024 Financial Results and..
11/11/202422:05GLOBEIO Biotech Announces Participation in Upcoming Investor..
07/11/202416:00GLOBEIO Biotech Reports its Off-the-Shelf Therapeutic Cancer..
04/10/202415:00GLOBEIO Biotech Announces Two Poster Presentations at the Society..
14/9/202408:30GLOBEIO Biotech Announces Positive Results from Phase 2 Trial of..
30/8/202422:10EDGAR2Form 8-K - Current report
30/8/202422:05GLOBEIO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103..
26/8/202422:05GLOBEIO Biotech Announces Participation in Upcoming Investor..
13/8/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202413:05EDGAR2Form 8-K - Current report
13/8/202413:05GLOBEIO Biotech Reports Second Quarter 2024 Financial Results and..
25/7/202422:05GLOBEIO Biotech Announces New Head and Neck Cohort Data Accepted..
11/6/202422:44EDGAR2Form 8-K - Current report
07/6/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202414:30GLOBEIO Biotech to Present at Jefferies Global Healthcare..
14/5/202414:30EDGAR2Form 8-K - Current report
14/5/202414:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202413:55GLOBEIO Biotech Reports First Quarter 2024 Financial Results and..
24/4/202422:30GLOBEIO Biotech Announces Abstract Accepted for Presentation at..
15/4/202414:30GLOBEIO Biotech Expands Senior Leadership Team to Progress..
09/4/202418:00GLOBEIO Biotech Presents New Data at AACR 2024 Further Supporting..
05/4/202414:30GLOBEIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business..
11/3/202421:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202422:11GLOBEIO Biotech Announces Acceptance of Abstract to be Presented..
05/3/202423:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202422:46EDGAR2Form 8-K - Current report
05/3/202422:40GLOBEIO Biotech Announces 2023 Fourth-Quarter and Year-End..
26/2/202422:05GLOBEIO Biotech to Present at 44th Annual Cowen Health Care..
08/1/202414:11EDGAR2Form 8-K - Current report
21/12/202314:30GLOBEIO Biotech Announces First Patient Dosed in Phase 2..
Apertura: Min: Max:
Chiusura: 0,8602

La tua Cronologia

NASDAQ
IOBT
IO Biotech
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network